NCT01517945

Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 252 (actual)
• Sponsor: Memorial Sloan Kettering Cancer Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to test, customize, and personalize a mobile app-based intervention program in order to help rare and breast cancer survivors cope with fears of cancer recurrence.

Conditions

• Breast Cancer
• Rare Cancer

Interventions

Type	Name	Description
BEHAVIORAL	AIM materials and assessments	Phase 1 (complete) - dev of AIM materials targeting fear of cancer recurrence in BCS (n = 10). Phase 2 (complete) - randomized, single-blind, placebo-controlled, proof-of-concept pilot trial. Phase 3: * Part 1 of Phase 3 (complete) - dev of of iThrive app for BCS * Part 2 of Phase 3 (complete) - usability testing by observing navigation with BCS in a laboratory setting * Part 3 of Phase 3 - acceptability of iThrive will be assessed through a small RCT (n=30) Phase 4: * Part 1 of Phase 4 (complete) - dev of iThrive app for RCS * Part 2 of Phase 4 (complete) - usability testing completed by observing navigation with RCS remotely * Part 3 of Phase 4 - acceptability of iThrive will be assessed through a small RCT (n=90) For Phases 3 and 4, Part 3: We will work with participants to ensure that sessions are completed over \< 12 weeks if unavoidable delays occur. A follow-up session will be scheduled 3 months after completion of the last session.

Timeline

• Start date: 2012-01-01
• Primary completion: 2027-01-01
• Completion: 2027-01-01
• First posted: 2012-01-25
• Last updated: 2026-02-20

Locations

1 site across 1 country: United States